<DOC>
	<DOC>NCT02845765</DOC>
	<brief_summary>The purpose of this study is to evaluate the correlation between fundus oculi's vascularization in patients with erectile dysfunction and not, and, in the same patients, before and after using drugs for ED.</brief_summary>
	<brief_title>Fundus Oculi and Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<mesh_term>Phosphodiesterase 5 Inhibitors</mesh_term>
	<criteria>Subjects with erectile dysfunction diagnosis (organic and psychogenic); Subjects with Erectile Dysfunction diagnosis defined by IIEF score â‰¤ 25 Subjects with stable partner for at least 6 months and sexually active. Subjects aged between 40 60 years; Signature of informed consent for patients Subjects with ED secondary diagnosis to hormonal alterations (i.e. hypogonadism, hypo / hyperthyroidism, hyperprolactinemia); Subjects with a diagnosis of ED posttraumatic and iatrogenic, since after pelvic surgery; Subjects suffering from any ocular pathology that involves use of contact lenses and / or glasses; Subjects smoking; Individuals with uncontrolled systemic diseases; All persons who do not confirm at least one criterion for inclusion.</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>ED</keyword>
	<keyword>Fundus Oculi</keyword>
	<keyword>Retinal Vascularization</keyword>
	<keyword>International Index of Erectile Function Questionnaire</keyword>
	<keyword>IIEF</keyword>
	<keyword>Dynamic Vessel Analyzer</keyword>
	<keyword>DVA</keyword>
	<keyword>Phosphodiesterase type 5 Inhibitor</keyword>
	<keyword>PDE5Is</keyword>
</DOC>